Foligraf 900IU Injection 1.5 ml

Foligraf 900IU Injection belongs to a group of medicines called Gonadotropins. It is used to treat infertility in women (oligo-anovulatory infertile patients in whom the cause of infertility is functional and not due to primary ovarian failure) and to stimulate sperm production in men.

Foligraf 900IU Injection contains a follicle-stimulating hormone, which acts by developing and ripening several follicles and inducing the ovulation procedure. In infertile men, Foligraf 900IU Injection is used along with other medicines to help produce sperm.

Foligraf 900IU Injection may cause certain side effects, such as headache, vomiting, diarrhoea, abdominal cramps, abdominal pain, fever, sore throat, sneezing, and pain at the injection site. These side effects are usually mild and temporary. Foligraf 900IU Injection will be administered by a trained healthcare doctor.

Before receiving Foligraf 900IU Injection , inform your doctor if you have a known allergy to Foligraf 900IU Injection or any contents present in it. Foligraf 900IU Injection is not recommended for patients with primary ovarian failure, and primary testicular failure, pregnant and breastfeeding women. Inform your doctor about your complete medical and medication history before receiving Foligraf 900IU Injection to rule out any side effects.

Foligraf 900IU Injection is used in the treatment of Female infertility and Hypogonadism. The detailed uses of Foligraf 900IU Injection are as follows:

• Treatment of Female Infertility: Foligraf 900IU Injection is used to stimulate ovarian follicular growth in women who do not have primary ovarian failure, helping develop and mature eggs for fertilization.
• Support in Assisted Reproductive Technologies (ART): Foligraf 900IU Injection promotes the development of multiple follicles in ovulatory women undergoing procedures like in vitro fertilization (IVF), enhancing the chances of successful embryo retrieval.
• Induction of Ovulation in Anovulatory Patients: Foligraf 900IU Injection is used to trigger ovulation in women with functional infertility, enabling timed conception or ART procedures.
• Stimulation of Spermatogenesis in Men: Foligraf 900IU Injection is used alongside other hormones to treat male hypogonadism by encouraging sperm production in men with low gonadotropin levels.

• Follow your doctor’s instructions on the dosage and timing of this medication.
• Foligraf 900IU Injection will be administered by a healthcare professional.
• Do not self-administer it.

Foligraf 900IU Injection contains ‘follicle-stimulating hormone used to treat fertility problems (usually given along with other medicines). In females, Foligraf 900IU Injection develops and ripens several follicles (containing eggs necessary for fertilization) in women undergoing assisted reproductive technologies (a procedure that helps to get pregnant). It also helps to induce the ovulation procedure (releasing an egg from the ovary). In males, it helps replenish the deficient testosterone (anabolic steroid and primary sex hormone in males) levels and helps produce sperm cells.

Before receiving Foligraf 900IU Injection , inform your doctor if you have any known allergies to this medicine or any contents present in it. Inform your doctor about your complete medical and medication history before receiving Foligraf 900IU Injection to rule out any side effects. Foligraf 900IU Injection is not recommended for patients with primary ovarian failure, primary testicular failure, an untreated or uncontrolled disorder of the thyroid gland, pituitary gland, or adrenal gland, abnormal vaginal bleeding, ovarian cyst, breast cancer, uterine cancer, and cancer of ovaries, testicle, hypothalamus, or pituitary gland. Inform your doctor about your complete medical and medication history before receiving Foligraf 900IU Injection to rule out any side effects. Inform your doctor if you have/had any history of stroke, blood clot, stomach surgery, unusual vaginal bleeding, PCOD, and liver/kidney disease. This medicine is contraindicated in pregnant women, breastfeeding mothers and children.